VNRX - VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q3 2021 Results - Earnings Call Transcript
VolitionRx Limited (VNRX) Q3 2021 Results Conference Call November 11, 2021 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Tom Butera - Chief Executive Officer of Volition Veterinary Diagnostics Development Conference Call Participants Bruce Jackson - The Benchmark Company Steven Ralston - Zacks Michael Okunewitch - Maxim Group Presentation Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Third Quarter 2021 Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be open for questions. [Operator Instructions] This conference call is being recorded today, November 11, 2021. I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead. Scott Powell Thank you, and welcome,
For further details see:
VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q3 2021 Results - Earnings Call Transcript